Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.72 is 152% below its 5-year average of -1.48, near the low end of its 5-year range (-4.36–-0.52).
35.27% below its 12-month average of -2.75.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.05.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:58:15.340Z. Historical observations retain their original dates. Historical series through 2019-04-01.
EARNINGS PER SHARE (EPS)
-3.72
EARNINGS PER SHARE (EPS) AVG TTM
-2.75
EARNINGS PER SHARE (EPS) AVG 3Y
-1.76
EARNINGS PER SHARE (EPS) AVG 5Y
-1.48
EARNINGS PER SHARE (EPS) AVG 10Y
-1.09
EARNINGS PER SHARE (EPS) AVG 15Y
-1.55
EARNINGS PER SHARE (EPS) AVG 20Y
-2.62
CURRENT VS TTM AVG
-35.27%
CURRENT VS 3Y AVG
-111.97%
CURRENT VS 5Y AVG
-151.92%
CURRENT VS 10Y AVG
-241.57%
CURRENT VS 15Y AVG
-140.44%
CURRENT VS 20Y AVG
-42.16%
Sanara MedTech Inc.
Market Cap
$321.76M
Earnings Per Share (EPS)
-3.72
TTM Avg
-2.75
3Y Avg
-1.76
5Y Avg
-1.48
Market Cap
$321.48M
Earnings Per Share (EPS)
-1.58
TTM Avg
-1.99
3Y Avg
-1.86
5Y Avg
-1.78
Market Cap
$320.59M
Earnings Per Share (EPS)
-1.18
TTM Avg
-0.80
3Y Avg
-0.80
5Y Avg
-0.72
Market Cap
$319.73M
Earnings Per Share (EPS)
-1.45
TTM Avg
-2.06
3Y Avg
-1.65
5Y Avg
-1.47
Market Cap
$318.98M
Earnings Per Share (EPS)
2.65
TTM Avg
-5.30
3Y Avg
-10.00
5Y Avg
-10.52
Market Cap
$324.92M
Earnings Per Share (EPS)
-0.63
TTM Avg
-0.48
3Y Avg
-0.42
5Y Avg
-0.42
Market Cap
$314.56M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.40
3Y Avg
-2.02
5Y Avg
-1.91
Market Cap
$302.32M
Earnings Per Share (EPS)
-0.98
TTM Avg
-1.02
3Y Avg
-4.71
5Y Avg
-10.90
Market Cap
$302.90M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.02
3Y Avg
-0.02
5Y Avg
-0.02
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sanara MedTech Inc. (SMTI) | $321.76M | -3.72 | -2.75 | -1.76 | -1.48 |
| Cabaletta Bio, Inc. (CABA)vs › | $321.48M | -1.58 | -1.99 | -1.86 | -1.78 |
| ClearPoint Neuro, Inc. (CLPT)vs › | $320.59M | -1.18 | -0.80 | -0.80 | -0.72 |
| Avita Medical Inc. (RCEL)vs › | $319.73M | -1.45 | -2.06 | -1.65 | -1.47 |
| Agenus Inc. (AGEN)vs › | $318.98M | 2.65 | -5.30 | -10.00 | -10.52 |
| CapsoVision, Inc. (CV)vs › | $324.92M | -0.63 | -0.48 | -0.42 | -0.42 |
| C4 Therapeutics, Inc. (CCCC)vs › | $314.56M | -1.00 | -1.40 | -2.02 | -1.91 |
| Benitec Biopharma Inc. (BNTC)vs › | $302.32M | -0.98 | -1.02 | -4.71 | -10.90 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $302.90M | N/A | -0.02 | -0.02 | -0.02 |
| Relmada Therapeutics, Inc. (RLMD)vs › | $349.18M | -0.92 | -2.05 | -3.17 | -3.94 |
Trailing EPS (TTM)
$-3.72
Forward EPS (Est.)
$0.19
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.36 |
| 2024-12-31 | -1.14 |
| 2023-12-31 | -0.52 |
| 2022-12-31 | -1.00 |
| 2021-12-31 | -1.08 |
| 2020-12-31 | -0.76 |
| 2019-12-31 | -1.37 |
| 2018-12-31 | -0.28 |
| 2017-12-31 | 0.17 |
| 2016-12-31 | -0.38 |
| 2015-12-31 | -1.26 |
| 2014-12-31 | -2.16 |
| 2013-12-31 | -4.84 |
| 2012-12-31 | -2.68 |
| 2011-12-31 | -21.69 |
| 2010-12-31 | -14.34 |
| 2009-12-31 | -7.92 |
| 2008-12-31 | -8.08 |
| 2007-12-31 | -3.36 |
| 2006-12-31 | -3.86 |
| 2005-12-31 | -4.84 |
| 2004-12-31 | -68.92 |
| 2001-12-31 | -2.15 |
| 2000-12-31 | -1.59 |
| 1999-12-31 | 0.69 |
